Evoke plc (LON:EVOK – Get Free Report) shares traded down 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
EVOK has been the topic of several research analyst reports. Berenberg Bank decreased their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
Read Our Latest Stock Analysis on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, equities research analysts forecast that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen bought 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- Where Do I Find 52-Week Highs and Lows?
- MarketBeat Week in Review – 03/24 – 03/28
- What Are the U.K. Market Holidays? How to Invest and Trade
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Read Stock Charts for Beginners
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.